CD4 T cells are critical for the control of gammaherpesvirus persistence, but their direct effector mechanisms of virus control in vivo are still poorly understood. In this study, we use murine gammaherpesvirus 68 (␥HV68) in in vitro and in vivo cytotoxicity assays to show CD4-dependent killing of ␥HV68-loaded cells in mice persistently infected with ␥HV68. Our results underscore the cytotoxic capacity of CD4 T cells during ␥HV68 persistence.
CD4 T cells are critical for the control of gammaherpesvirus persistence, but their direct effector mechanisms of virus control in vivo are still poorly understood. In this study, we use murine gammaherpesvirus 68 (␥HV68) in in vitro and in vivo cytotoxicity assays to show CD4-dependent killing of ␥HV68-loaded cells in mice persistently infected with ␥HV68. Our results underscore the cytotoxic capacity of CD4 T cells during ␥HV68 persistence.
There is mounting evidence that during chronic or persistent viral infections, effector CD4 T cells have the ability to display cytotoxic characteristics (7, 8, 18) . CD4 T cells with cytotoxic potential have been characterized during persistent human immunodeficiency virus and human cytomegalovirus infections (2, 4, 19) . There are also extensive reports describing antigenspecific cytolytic CD4 T-cell cultures during persistent EpsteinBarr virus infection in humans (1, 9, 10, 12, 13, 17) . Whether effector CD4 T cells use cytotoxic abilities and/or other mechanisms to eliminate virus-infected cells during persistent gammaherpesvirus infection in vivo remains unknown.
We first analyzed the existence of CD4 T cells with a cytotoxic phenotype in mice persistently infected with gammaherpesvirus 68 (␥HV68) (1,000 PFU in 30 l of phosphate-buffered saline, administered intranasally). Reduced surface expression of CD27 has been used as a marker of cytotoxic T cells (2) . As shown in Fig. 1 , the frequency of CD4 T cells lacking cell surface expression of CD27 increases from 10% in noninfected mice to 40% in the spleens and 80% in the lungs of mice at 3 months after ␥HV68 infection. The loss of CD27 expression during ␥HV68 herpesvirus latency suggested an increase in the frequency of CD4 T cells that may have a cytolytic phenotype. Next, we sought to analyze the potential of CD4 T cells to act as killers. We used CD107a and CD107b (CD107a/b) cell surface mobilization as an indicator of in vitro degranulation associated with cytolytic function (3). Splenocytes (10 6 ) obtained from the spleens of naive or long-term ␥HV68-infected mice were incubated with anti-CD28 (clone 37.51), anti-CD49d (clone 9C10 [MRF4.B]), anti-CD107a (clone 1D4B), and anti-CD107b (clone ABL-93) and stimulated with 2 g/ml of gp150 67-83 peptide, whole ␥HV68 virus (multiplicity of infection [MOI], 10), or phorbol myristate acetate/ionomycin or not stimulated (Fig. 1C) . The cell suspensions were incubated for 1 h at 37°C followed by an additional 4 h in the presence of the secretion inhibitor monensin, and cell surface expression levels of CD4 (clone GK1.5), CD8 (clone 53.6.72), and CD107a/b were determined by flow cytometry. The data show that CD4 T cells isolated from the spleens of latently infected mice mobilize significantly more CD107a/b to the cell surface (4%) than their naïve counterparts (2%) (Fig. 1D) . The pattern of degranulation of CD4 T cells isolated from ␥HV68-infected mice was similar in the presence or absence of exogenous in vitro restimulation. These results show that there is a statistically significant difference in CD107a/b mobilization between CD4 T cells isolated from naïve and ␥HV68-infected mice, and this difference is independent of exogenous restimulation. This pattern of degranulation is specific to CD4 T cells, as steady-state CD107a/b expression is not observed with CD8 T-cell splenocytes from ␥HV68-infected mice (Fig. 1E) , a result which suggests that carryover of viral antigens by host cells during the in vitro incubation is not the cause of the observed CD107a/b mobilization on CD4 T cells. Collectively, the CD27 profile and the CD107a/b mobilization data suggest that during ␥HV68 persistence, CD4 T cells acquire a cytolytic phenotype.
To examine the ␥HV68-specific cytotoxic activity of CD4 T cells from persistently ␥HV68-infected mice, we used an in vitro chromium release assay. L fibroblasts (H-2 k ) stably expressing IA b molecules on their cell surface (L-IA b ) were used as antigen-presenting target cells. L-IA b cells were pulsed with ␥HV68, labeled with 51 Cr, and incubated at various ratios with purified CD4 T-cell splenocytes (95% purity) isolated from long-term ␥HV68-infected mice. CD4 T cells were purified to avoid killing mediated by other cell populations. In addition, to determine whether the killing was major histocompatibility complex (MHC) class IA b mediated, we used purified CD4 T cells isolated from persistently infected C57BL/6J mice (H- fibroblasts resulted in measurable and dose-dependent specific lysis (Fig. 2) . However, CD4 T cells purified from ␥HV68-infected BALB/c mice were not able to induce specific lysis of ␥HV68-loaded L-IA b cells at any of the ratios tested (100:1 to 1:1). These findings indicate that CD4 T cells from ␥HV68-infected mice are capable of killing ␥HV68-loaded target cells in vitro by an MHC-restricted process. Next, we used flow cytometry staining to analyze the expression of the cytotoxicity mediators perforin, granzyme B, FasL, and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand). The data (Fig. 2B) show that expression of these molecules could not be detected by flow cytometry on CD4 T cells isolated from the spleens of ␥HV68-infected mice.
To determine the biological significance of these in vitro findings and whether CD4 T cells could act as killers in mice, we performed in vivo cytotoxicity assays using ␥HV68-latently infected mice. To confirm that any observed cytotoxicity is not due to the presence of CD8 effector functions, CD8 T cells were depleted prior to the transfer of target cells. To do so, ␥HV68-infected and naïve control mice were depleted of CD8 T cells in vivo by intraperitoneal injections of 250 g of anti-CD8 antibody (clone 2.43) on alternate days for 1 week prior to the transfer of target cells (Fig. 3A) . The efficiency of the CD8 T-cell depletion was confirmed using a different anti-CD8 antibody (clone 53-6.72) (Fig. 3B) . Antigen-presenting cells obtained from the spleens of naïve mice were pulsed with ␥HV68 (MOI, 10) or not (nonspecific killing control) and labeled with different concentrations of carboxyfluorescein succinimidyl ester (CFSE), mixed at a 1:1 ratio and intravenously injected into naïve control mice or into mice persistently infected with ␥HV68 that had been depleted of CD8 T cells. Recipient mice were sacrificed 40 h later, and the frequency of CFSE-positive target cells was measured to determine the per- centage of specific lysis. The percent specific killing was calculated according to the following formula: percent specific killing ϭ[1Ϫ (ratio of naive recipients/ratio of infected recipients) ϫ 100], where ratio ϭ (number of CFSE low /number of CFSE high ). We analyzed mice during early latency (20 days after infection) and late latency (90 days after infection). The data show that during both the early and the late phase of viral latency, persistently infected CD8-depleted mice are capable of specifically killing ␥HV68-loaded targets (Fig. 3C ). The analysis of in vivo cytotoxicity in CD8-depleted mice using shorter intervals of time (6 h) did not yield specific target lysis (data not shown). Importantly, the percent specific killing was calculated by using the ratio of ␥HV68-loaded cells/unloaded cells in both noninfected and ␥HV68-infected mice. This calculation implies that the specific lysis is not observed in noninfected CD8-depleted mice or with target cells that have not been loaded with ␥HV68, indicating that non-␥HV68-specific or indirect mechanisms cannot account for the lysis of target cells. It should also be noted that during late latency, the percentage of specific lysis in vivo in the absence of CD8 T cells increases modestly, from 12% to 23%, as latent infection progresses (Fig. 3C) , which is in stark contrast to the pattern of CD8 T-cell-mediated cytotoxicity, which peaks early during infection and is followed by a dramatic reduction by 3 months postinfection (6, 16) . These experiments indicate that CD8 T cells do not make a significant contribution to the killing of ␥HV68-loaded targets during an in vivo cytotoxicity assay.
To further confirm that ␥HV68-specific lysis is mediated by CD4 T cells in vivo, we performed similar cytotoxicity assays in which CD4 T cells were depleted in the mouse. Intraperitoneal injections of 250 g of anti-CD4 antibody (clone GK1.5) on alternate days for 1 week (Fig. 4A ) resulted in a sufficient depletion of CD4, which was confirmed by using a different anti-CD4 antibody (clone RM4-5) (Fig. 4B) . Antigen-presenting cells obtained from the spleens of naïve mice were pulsed with ␥HV68 (MOI, 10) or not (nonspecific killing control) and labeled with different concentrations of CFSE, mixed at a 1:1 ratio, and intravenously injected into naïve control mice or into mice persistently infected with ␥HV68 that had been depleted of CD4 T cells. The percent specific killing was calculated as indicated above. The data show that the killing of ␥HV68- loaded targets was abrogated in the mice depleted of CD4 T cells but not in the mice that received control immunoglobulin G (IgG) treatment (Fig. 4C ). These data demonstrate that CD4 T cells are responsible for the in vivo killing of ␥HV68-loaded targets.
In summary, our results provide compelling phenotypic and functional evidence for the existence of virus-specific cytolytic CD4 T cells during persistent ␥HV68 infection. In addition, they provide the first in vivo evidence for CD4 T-cell-mediated cytotoxicity during gammaherpesvirus infections. It has been demonstrated that CD4 T cells can control ␥HV68 infection independently of CD8 T cells, B cells, or antibodies (11, 15) . Our data indicate that CD4 T-cell control of ␥HV68 infection not only is mediated by IFN-␥ (5, 14) but also can be mediated by direct cytotoxicity. Several mechanisms have been implicated during in vitro killing by CD4 T cells, and further studies will be necessary to clarify the mechanisms employed in vivo during ␥HV68 infection.
